Apyx Medical Corporation (APYX)
NASDAQ: APYX · IEX Real-Time Price · USD
1.340
+0.040 (3.08%)
Jul 2, 2024, 4:30 PM EDT - Market closed

Apyx Medical Revenue

Apyx Medical had revenue of $50.45M in the twelve months ending March 31, 2024, with 14.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.24M, a -15.63% decrease year-over-year. In the year 2023, Apyx Medical had annual revenue of $52.35M with 17.61% growth.

Revenue (ttm)
$50.45M
Revenue Growth
+14.25%
P/S Ratio
0.92
Revenue / Employee
$200,202
Employees
252
Market Cap
46.42M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202352.35M7.84M17.61%
Dec 31, 202244.51M-4.01M-8.26%
Dec 31, 202148.52M20.81M75.08%
Dec 31, 202027.71M-524.00K-1.86%
Dec 31, 201928.24M11.63M70.04%
Dec 31, 201816.61M6.37M62.25%
Dec 31, 201710.23M1.42M16.04%
Dec 31, 20168.82M-20.70M-70.13%
Dec 31, 201529.52M1.84M6.64%
Dec 31, 201427.68M4.02M16.99%
Dec 31, 201323.66M-4.01M-14.50%
Dec 31, 201227.67M2.26M8.89%
Dec 31, 201125.41M1.18M4.87%
Dec 31, 201024.23M-2.72M-10.10%
Dec 31, 200926.95M-1.14M-4.07%
Dec 31, 200828.10M-682.16K-2.37%
Dec 31, 200728.78M2.10M7.88%
Dec 31, 200626.68M6.47M31.99%
Dec 31, 200520.21M-283.96K-1.39%
Dec 31, 200420.50M4.38M27.16%
Dec 31, 200316.12M3.67M29.50%
Dec 31, 200212.45M913.76K7.92%
Dec 31, 200111.53M1.60M16.07%
Dec 31, 20009.94M243.17K2.51%
Dec 31, 19999.69M1.25M14.82%
Dec 31, 19988.44M1.07M14.52%
Dec 31, 19977.37M-114.62K-1.53%
Dec 31, 19967.49M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 75.80M
Augmedix 48.70M
Cytosorbents 36.69M
Marker Therapeutics 3.32M
vTv Therapeutics 1.00M
Revenue Rankings